1. Sperling MA. Sperling pediatric endocrinology E-Book. Amsterdam (The Netherlands): Elsevier Health Sciences. 2020.
5. Ulloa-Aguirre A, Reiter E, Crépieux P. FSH receptor signaling: complexity of interactions and signal diversity. Endocrinology 2018;159:3020–35.
6. He WB, Du J, Yang XW, Li W, Tang WL, Dai C, et al. Novel inactivating mutations in the FSH receptor cause premature ovarian insufficiency with resistant ovary syndrome. Reprod Biomed Online 2019;38:397–406.
7. Aittomäki K, Herva R, Stenman UH, Juntunen K, Ylöstalo P, Hovatta O, et al. Clinical features of primary ovarian failure caused by a point mutation in the follicle-stimulating hormone receptor gene. J Clin Endo crinol Metab 1996;81:3722–6.
8. Shemesh M. Actions of gonadotrophins on the uterus. Reproduction 2001;121:835–42.
10. Danilovich N, Roy I, Sairam MRJE. Emergence of uterine pathology during accelerated biological aging in FSH receptor-haploinsufficient mice. Endocrinology 2002;143:3618–27.
11. Sun L, Peng Y, Sharrow AC, Iqbal J, Zhang Z, Papachristou DJ, et al. FSH directly regulates bone mass. Cell 2006;125:247–60.
12. Kim NK, Lee SH, Nam YS, Sohn TJ, Park SH, Park C, et al. Molecular variants of the FSH receptor exon 10 (Thr307Ala; A919G) in premature ovarian failure (POF) women by PCR-SSCP. Korean J Obstet Gynecol 2000;43:1144–6.
13. Choi YM, Kim SH, Kim JK, Moon SY, Lee JY, Lee GW. Follicle stimulating hormone receptor gene mutation in Korean women with premature ovarian failure and normal karyotype. Korean J Obstet Gynecol 2001;43:836–41.
14. Nam Y, Kim N, Choi M, Park S, Chung K, Lee S, et al. Analysis of follicle stimulating hormone receptor gene mutation in Korean. Clin Exp Reprod Med 1998;25:281–6.
16. Liu H, Xu X, Han T, Yan L, Cheng L, Qin Y, et al. A novel homozygous mutation in the FSHR gene is causative for primary ovarian insufficiency. Fertil Steril 2017;108:1050–5.e2.
21. Nakamura Y, Maekawa R, Yamagata Y, Tamura I, Sugino N. A novel mutation in exon8 of the follicle-stimulating hormone receptor in a woman with primary amenorrhea. Gynecol Endocrinol 2008;24:708–12.
22. Allen LA, Achermann JC, Pakarinen P, Kotlar TJ, Huhtaniemi IT, Jameson JL, et al. A novel loss of function mutation in exon 10 of the FSH receptor gene causing hypergonadotrophic hypogonadism: clinical and molecular characteristics. Hum Reprod 2003;18:251–6.
23. Meduri G, Touraine P, Beau I, Lahuna O, Desroches A, Vacher-Lavenu MC, et al. Delayed puberty and primary amenorrhea associated with a novel mutation of the human follicle-stimulating hormone receptor: clinical, histological, and molecular studies. J Clin Endocrinol Metab 2003;88:3491–8.
27. Gromoll J, Simoni M, Nordhoff V, Behre HM, De Geyter C, Nieschlag E. Functional and clinical consequences of mutations in the FSH receptor. Mol Cell Endocrinol 1996;125:177–82.
28. Aittomäki K, Lucena JL, Pakarinen P, Sistonen P, Tapanainen J, Gromoll J, et al. Mutation in the follicle-stimulating hormone receptor gene causes hereditary hypergonadotropic ovarian failure. Cell 1995;82:959–68.